Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections

Human Immunology

Volumn 74, Issue 5, 2013, Pages 522-530

  Nuutila, Jari ^a   Jalava Karvinen, Päivi ^b   Hohenthal, Ulla ^b   Kotilainen, Pirkko ^b   Pelliniemi, Tarja Terttu ^b   Nikoskelainen, Jukka ^b   Lilius, Esa Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

CBI INDEX; CM INDEX; LympCD35 ; LympCD55 ; LympCD59

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEVER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MONOCYTE; MONONUCLEOSIS; NEUTROPHIL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIRAL MONONUCLEOSIS; VIRUS INFECTION;

ADULT; AGED; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; COMPLEMENT INACTIVATOR PROTEINS; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HUMANS; INFECTIOUS MONONUCLEOSIS; LEUKOCYTES; LYMPHOCYTES; MIDDLE AGED; MONOCYTES; NEUTROPHILS; RECEPTORS, COMPLEMENT 3B; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84876325837     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.01.011     Document Type: Article

References (28)

1. Heller A., Kunz M., Samakas A., Haase M., Kirschfink M., Koch T. The complement regulators C1 inhibitor and soluble complement receptor 1 attenuate acute lung injury in rabbits. Shock 2000, 13(4):285.
2. Kim D.D., Song W.C. Membrane complement regulatory proteins. Clin Immunol 2006, 118(2-3):127.
3. Krych M., Hauhart R., Atkinson J.P. Structure-function analysis of the active sites of complement receptor type 1. J Biol Chem 1998, 273(15):8623.
4. Hourcade D., Holers V.M., Atkinson J.P. The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989, 45:381.
5. Tas S.W., Klickstein L.B., Barbashov S.F., Nicholson-Weller A. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion. J Immunol 1999, 163(9):5056.
6. Farkas I., Baranyi L., Ishikawa Y., Okada N., Bohata C., Budai D., et al. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9. J Physiol 2002, 539(Pt 2):537.
7. Meri S., Morgan B.P., Davies A., Daniels R.H., Olavesen M.G., Waldmann H., et al. Human protectin (CD59), an 18,000-20,000MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 1990, 71(1):1.
8. van de Winkel J.G., Capel P.J. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993, 14(5):215.
9. Zhou M.J., Brown E.J. CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation. J Cell Biol 1994, 125(6):1407.
10. Worth R.G., Mayo-Bond L., van de Winkel J.G., Todd R.F., Petty H.R. CR3 (alphaM beta2; CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective Fc gammaRIIA (CD32) tail-minus mutant. J Immunol 1996, 157(12):5660.
11. Cohen J.H., Atkinson J.P., Klickstein L.B., Oudin S., Subramanian V.B., Moulds J.M. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms. Mol Immunol 1999, 36(13-14):819.
12. Elghetany M.T. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis 2002, 28(2):260.
13. Nuutila J., Jalava-Karvinen P., Hohenthal U., Laitinen I., Kotilainen P., Rajamaki A., et al. Comparison of degranulation of easily mobilizable intracellular granules by human phagocytes in healthy subjects and patients with infectious diseases. Hum Immunol 2009.
14. Jalava-Karvinen P., Hohenthal U., Laitinen I., Kotilainen P., Rajamaki A., Nikoskelainen J., et al. Simultaneous quantitative analysis of Fc gamma RI (CD64) and CR1 (CD35) on neutrophils in distinguishing between bacterial infections, viral infections, and inflammatory diseases. Clin Immunol 2009, 133(3):314.
15. Nuutila J., Hohenthal U., Laitinen I., Kotilainen P., Rajamaki A., Nikoskelainen J., et al. Quantitative analysis of complement receptors, CR1 (CD35) and CR3 (CD11b), on neutrophils improves distinction between bacterial and viral infections in febrile patients: comparison with standard clinical laboratory data. J Immunol Methods 2006, 315(1-2):191.
16. Nuutila J., Lilius E.M. Distinction between bacterial and viral infections. Curr Opin Infect Dis 2007, 20(3):304.
17. Kumar A., Wetzler E., Berger M. Isolation and characterization of complement receptor type 1 (CR1) storage vesicles from human neutrophils using antibodies to the cytoplasmic tail of CR1. Blood 1997, 89(12):4555.
18. Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol 2004, 78(9):4385.
19. Liszewski M.K., Kemper C., Price J.D., Atkinson J.P. Emerging roles and new functions of CD46. Springer Semin Immunopathol 2005, 27(3):345.
20. Gerlier D., Trescol-Biemont M.C., Varior-Krishnan G., Naniche D., Fugier-Vivier I., Rabourdin-Combe C. Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells. J Exp Med 1994, 179(1):353.
21. de Grooth B.G., Terstappen L.W., Puppels G.J., Greve J. Light-scattering polarization measurements as a new parameter in flow cytometry. Cytometry 1987, 8(6):539.
22. Bewick V., Cheek L., Ball J. Statistics review 13: receiver operating characteristic curves. Crit Care 2004, 8(6):508.
23. Nuutila J., Hohenthal U., Laitinen I., Kotilainen P., Rajamaki A., Nikoskelainen J., et al. Simultaneous quantitative analysis of FcgammaRI (CD64) expression on neutrophils and monocytes: a new, improved way to detect infections. J Immunol Methods 2007, 328(1-2):189.
24. Nuutila J., Hohenthal U., Laitinen I., Kotilainen P., Rajamaki A., Nikoskelainen J., et al. A novel method for distinguishing between dsDNA and ssRNA virus infections. J Clin Virol 2008, 43(1):49.
25. Nuutila J., Jalava-Karvinen P., Hohenthal U., Laitinen I., Kotilainen P., Rajamaki A., et al. CRP/CD11b ratio: a novel parameter for detecting gram-positive sepsis. Hum Immunol 2009, 70(4):237.
26. Rivers E.P., McIntyre L., Morro D.C., Rivers K.K. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 2005, 173(9):1054.
27. Luzuriaga K., Sullivan J.L. Infectious mononucleosis. N Engl J Med 1993, 362(21).
28. Stoermer K.A., Morrison T.E. Complement and viral pathogenesis. Virology 2011, 411(2):362.